European Shorting
BSPM has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
BSPM has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 1.137 |
BSPM's Cash to Debt is ranked higher than
60% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 1.63 vs. BSPM: 1.137 ) |
BSPM'
s 10-Year Cash to Debt Range
Min: 1.14 Max: No Debt Current: 1.14 |
| Equity to Asset | 0.82 |
BSPM's Equity to Asset is ranked higher than
85% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 0.59 vs. BSPM: 0.82 ) |
BSPM'
s 10-Year Equity to Asset Range
Min: 0.8 Max: 0.92 Current: 0.82 |
| Interest Coverage | No Debt |
BSPM's Interest Coverage is ranked higher than
88% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 12.70 vs. BSPM: No Debt ) |
BSPM'
s 10-Year Interest Coverage Range
Min: 85 Max: No Debt Current: No Debt |
| F-Score: 1 |
|
| Z-Score: 1.15 |
|
| M-Score: -2.54 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | -44.20 |
BSPM's Operating margin (%) is ranked lower than
63% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 7.80 vs. BSPM: -44.20 ) |
BSPM'
s 10-Year Operating margin (%) Range
Min: -44.2 Max: 30.5 Current: -44.2 |
| Net-margin (%) | -40.5 |
BSPM's Net-margin (%) is ranked lower than
63% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 6.00 vs. BSPM: -40.5 ) |
BSPM'
s 10-Year Net-margin (%) Range
Min: -40.5 Max: 25 Current: -40.5 |
| ROE (%) | -34.6 |
BSPM's ROE (%) is ranked lower than
64% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 5.50 vs. BSPM: -34.6 ) |
BSPM'
s 10-Year ROE (%) Range
Min: -34.6 Max: 28.8 Current: -34.6 |
| ROA (%) | -28.4 |
BSPM's ROA (%) is ranked lower than
64% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 3.40 vs. BSPM: -28.4 ) |
BSPM'
s 10-Year ROA (%) Range
Min: -28.4 Max: 25.5 Current: -28.4 |
| ROC (Joel Greenblatt) (%) | -61.20 |
BSPM's ROC (Joel Greenblatt) (%) is ranked lower than
67% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 11.40 vs. BSPM: -61.20 ) |
BSPM'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -61.2 Max: 82.8 Current: -61.2 |
| Revenue Growth (%) | -5.9 |
BSPM's Revenue Growth (%) is ranked lower than
61% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 0.00 vs. BSPM: -5.9 ) |
BSPM'
s 10-Year Revenue Growth (%) Range
Min: -5.9 Max: 40 Current: -5.9 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/B | 0.10 |
BSPM's P/B is ranked higher than
99% of the 621 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 2.46 vs. BSPM: 0.10 ) |
BSPM'
s 10-Year P/B Range
Min: 0.1 Max: 3.21 Current: 0.1 |
| P/S | 0.20 |
BSPM's P/S is ranked higher than
98% of the 654 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 2.68 vs. BSPM: 0.20 ) |
BSPM'
s 10-Year P/S Range
Min: 0.13 Max: 2.2 Current: 0.2 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 0.3 |
BSPM's Price/Net Current Asset Value is ranked higher than
99% of the 557 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 14.20 vs. BSPM: 0.3 ) |
BSPM'
s 10-Year Price/Net Current Asset Value Range
Min: 0.4 Max: 7.1 Current: 0.3 |
| Price/Tangible Book | 0.2 |
BSPM's Price/Tangible Book is ranked higher than
99% of the 535 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 3.10 vs. BSPM: 0.2 ) |
BSPM'
s 10-Year Price/Tangible Book Range
Min: 0.2 Max: 3.6 Current: 0.2 |
| Price/Median PS Value | 0.5 |
BSPM's Price/Median PS Value is ranked higher than
93% of the 596 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 1.10 vs. BSPM: 0.5 ) |
BSPM'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 5.8 Current: 0.5 |
| Earnings Yield (Greenblatt) | 9146.30 |
BSPM's Earnings Yield (Greenblatt) is ranked higher than
100% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 3.80 vs. BSPM: 9146.30 ) |
BSPM'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 12.2 Max: No Debt Current: 9146.3 |
| Forward Rate of Return (Yacktman) | 53.56 |
BSPM's Forward Rate of Return (Yacktman) is ranked higher than
99% of the 709 Companies in the Global Drug Manufacturers - Major industry. ( Industry Median: 0.00 vs. BSPM: 53.56 ) |
BSPM'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0 Max: 0 Current: 53.56 |
| Industry: | Drug Manufacturers - Major | |
|---|---|---|
| Compare: | ||
| Traded in other countries: | 7BNA.Germany |
| Weekly CFO Buys Highlight: ANADIGICS Inc., Biostar Pharmaceuticals Inc., Astrotech Corp. May 30 2011 |
Feedback
My Portfolios
Browse Gurus
Bookmark
Add to Portfolio
Get Email Alerts
RSS Update
Company Website
SEC Reports
RSS